Ari Fujishiro
MC, Investor Relations & Shareholder Relations
Replay available
Daiichi Sankyo Co Ltd Ord (DSKYF) Q4 2025 Earnings Call
Daiichi Sankyo Co Ltd Ord (OTC: DSKYF) Q4 2025 earnings conference call, held 2026-05-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Tomohiro Kodama
Senior Executive Officer, CFO
Ken Keda
Director, Head of Oncology Business Unit
John Tsai
Head of Global R&D
Yuki Abe
Senior Executive Officer, Head of R&D Division
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Daiichi Sankyo Company, Limited.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.031 Thank 00:00:02.134 -- 00:00:07.300 you for waiting. We are going to start Daichi Sankyo's FI2025 financial 00:00:07.300 -- 00:00:12.447 results announcement and FI2026 FI2035 year business 00:00:12.447 -- 00:00:15.788 plan presentation and discussion. 00:00:15.891 -- 00:00:21.418 I'm delighted to serve as MC today. I'm Ari Fujishiro from the investor relations 00:00:21.418 -- 00:00:25.883 and shareholder relations department. First about the language. 00:00:25.883 -- 00:00:30.389 In this briefing session, you're going to use Japanese and English. 00:00:30.389 -- 00:00:35.536 simultaneous translation is available. Please click the interpretation icon at the bottom 00:00:35.536 -- 00:00:41.402 of your Zoom screen and choose Japanese, English or the original audio. 00:00:41.465 -- 00:00:46.532 If you choose the original audio, you can listen to the original sound. 00:00:46.532 -- 00:00:51.659 On Zoom screen and during live streaming, we will show a presentation material in 00:00:51.659 -- 00:00:56.747 Japanese. We have posted a presentation in both Japanese and English on our corporate 00:00:56.747 -- 00:01:02.147 website and the IR library Financial Results Presentation Material or IR 00:01:02.147 -- 00:01:05.168 Presentation Material section. 00:01:05.932 -- 00:01:10.176 Please download the files if necessary. Today, 00:01:10.839 -- 00:01:15.826 five members are in attendance. Representative Director, President and CEO, Hiroyuki 00:01:15.826 -- 00:01:20.894 Okuzawa, Senior Executive Officer, CFO, Tomohiro Kodama, Director, Head 00:01:20.894 -- 00:01:24.258 of Oncology Business Unit, Ken Keda, 00:01:24.258 -- 00:01:29.540 Head of Global R&D, John Tsai, and Senior Executive Officer, Head of 00:01:29.540 -- 00:01:32.921 R&D Division, Y...